Daily startup and blockchain data-wiki with interviews, Q&A's & discussions about funding rounds & investors.

RaisedToday moderators manually update and approve wiki edits - check back every 1-2h for approved submissions.

Contributed by laura998

Ironwood Pharmaceuticals

10 Disclosed Funding Rounds $634,000,000

0 Participating Investments


Pharmaceutical, Health Care, Biotechnology

Ironwood Pharmaceuticals is an entrepreneurial pharmaceutical company, develops drugs for gastrointestinal and cardiovascular diseases.

Cambridge, Massachusetts, United States, North America (US)

Organizations in Cambridge in Pharmaceutical,
Organizations in Cambridge in Health Care,
Organizations in Cambridge in Biotechnology,
Organizations in Massachusetts in Pharmaceutical,
Organizations in Massachusetts in Health Care,
Organizations in Massachusetts in Biotechnology,
Organizations in United States in Pharmaceutical,
Organizations in United States in Health Care,
Organizations in United States in Biotechnology,
Organizations in North America in Pharmaceutical,
Organizations in North America in Health Care,
Organizations in North America in Biotechnology

Investors in Cambridge in Pharmaceutical,
Investors in Cambridge in Health Care,
Investors in Cambridge in Biotechnology,
Investors in Massachusetts in Pharmaceutical,
Investors in Massachusetts in Health Care,
Investors in Massachusetts in Biotechnology,
Investors in United States in Pharmaceutical,
Investors in United States in Health Care,
Investors in United States in Biotechnology,
Investors in North America in Pharmaceutical,
Investors in North America in Health Care,
Investors in North America in Biotechnology

Greater Boston Area (0 Investors) (0 Startups), New England (0 Investors) (0 Startups), East Coast (0 Investors) (0 Startups), Northeastern US (0 Investors) (0 Startups)

Founded date 01, 1998

Founders Brian M. Cali, Peter M. Hecht, Joseph C. Cook, Gina Bornino Miller

Operating Status Active

Funding Stage IPO

Last Funding Type Post-IPO Debt

Also known as Ironwood

Company Type For Profit


Facebook Link

Twitter Link

LinkedIN Link

Wikipedia Link

Ironwood Pharmaceuticals is an entrepreneurial pharmaceutical company, engages in developing and marketing human medicines. It engages in developing a pipeline of clinical candidates in the areas of gastrointestinal diseases, cardiovascular diseases, pain, and inflammation. The company's operationally independent subsidiary, Microbia Inc., engages in developing and commercializing bioprocesses for use in pharmaceuticals, foods, and specialty and industrial chemicals. Ironwood Pharmaceuticals, Inc. was formerly known as Microbia, Inc. The company was founded in 1998 and is headquartered in Cambridge, Massachusetts.

Date Round Raised Lead
September, 26, 2016 Post-IPO Debt $150,000,000 -------
January, 10, 2013 Post-IPO Debt $175,000,000 -------
September, 04, 2009 Venture - Series Unknown $25,000,000 -------
October, 01, 2008 Series G $50,000,000 -------
March, 01, 2007 Series F $50,000,000 Venrock, Morgan Stanley
February, 01, 2006 Series E $75,000,000 Venrock
May, 01, 2004 Series D $50,000,000 -------
April, 01, 2002 Series C $26,000,000 Venrock
November, 01, 2000 Series B $23,000,000 Venrock
January, 01, 1999 Series A $10,000,000 Venrock

Ironwood Pharmaceuticals Investors (10)

Investor Lead? Round Participating Raise Date Partners
Polaris Partners No Venture - Series Unknown $25,000,000 September, 04, 2009 -------
Venrock Yes Series F $50,000,000 March, 01, 2007 -------
Morgan Stanley Yes Series F $50,000,000 March, 01, 2007 -------
Venrock Yes Series E $75,000,000 February, 01, 2006 -------
Venrock No Series D $50,000,000 May, 01, 2004 -------
GGV Capital No Series D $50,000,000 May, 01, 2004 -------
Venrock Yes Series C $26,000,000 April, 01, 2002 -------
F-Prime Capital No Series C $26,000,000 April, 01, 2002 -------
Venrock Yes Series B $23,000,000 November, 01, 2000 -------
Venrock Yes Series A $10,000,000 January, 01, 1999 -------